EDP Sciences logo
Search
Menu
All issues Volume 39 / No 2 (March-April 2008) Vet. Res., 39 2 (2008) 16 References
Free Access
Issue
Vet. Res.
Volume 39, Number 2, March-April 2008
Number of page(s) 11
DOI https://doi.org/10.1051/vetres:2007054
Published online 16 January 2008
How to cite this article Vet. Res. (2008) 39:16
References of  Vet. Res. (2008) 39:16
  1. Acha P.N., Arambulo P.V., Rabies in the tropics - history and current status, in: Kuwert E., Merieux C., Koprowski H., Bogel K. (Eds.), Rabies in the Tropics, Springer-Verlag, New York, USA, 1985.
  2. Aguilar-Setién A., León-Campos Y., Tesoro-Cruz E., Kretschmer R., Brochier B., Pastoret P.P., Vaccination of vampire bats using a recombinant vaccinia-rabies virus, J. Wildl. Dis. (2002) 38:539-544 [PubMed].
  3. Aguilar-Setién A., Aguila-Tecuatl H., Tesoro-Cruz E., Ramos-Ramírez L., Kretschmer R., Preservation of rabies virus RNA from brain tissue using glycerina, Trans. R. Soc. Trop. Med. Hyg. (2003) 97:1-3 [CrossRef] [PubMed].
  4. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B., DNA vaccination: transfection and activation of dendritic cells as key events for immunity, J. Exp. Med. (1999) 189:169-178 [CrossRef] [PubMed].
  5. Atanasiu P., Perrin P., Microméthode immunoenzymatique de titrage des anticorps antirabiques : utilisation de la glycoprotéine rabique et de la protéine conjuguées à la peroxydase, Ann. Inst. Pasteur Microbiol. (1979) 7:213-220.
  6. Bahloul C., Jacob Y., Tordo N., Perrin P., DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses, Vaccine (1998) 16:417-425 [CrossRef] [PubMed].
  7. Bourhy H., Sureau P., Laboratory methods for rabies diagnosis, Institut Pasteur, Paris, France, 1999.
  8. Brochier B., Blancou J., Thomas I., Languet B., Artois M., Kieny M.P., Lecocq J.P., Costy F., Desmettre P., Chappuis G., Pastoret P.P., Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies. Innocuity to several non target bait consuming species, J. Wildl. Dis. (1989) 25:540-547 [PubMed].
  9. Cliquet F., Verdier Y., Sagné L., Aubert M., Schereffer J.L., Selve M., Wasniewski M., Servat A., Neutralizing antibodies titration in 25 000 sera dogs and cats vaccinated against rabies in France, in the framework of the new regulations that offer an alternative to quarantine, Rev.-Off. Int. Epizoot. (2003) 22:857-866.
  10. Cupillard L., Juillard V., Latour S., Colombet G., Cachet N., Richard S., Blanchard S., Fischer L., Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats, Vaccine (2005) 23:1910-1916 [CrossRef] [PubMed].
  11. Da Rosa E.S., Kotait I., Barbosa T.F., Carrieri M.L., Brandão P.E., Pinheiro A.S., Begot A.L., Wada M.Y., de Oliveira R.C., Grisard E.C., Ferreira M., Lima R.J., Montebello L., Medeiros D.B., Sousa R.C., Bensabath G., Carmo E.H., Vasconcelos P.F., Bat-transmitted human rabies outbreaks, Brazilian Amazon, Emerg. Infect. Dis. (2006) 12:1197-1202 [PubMed].
  12. Delpietro H., Fábregas F., Díaz M., Riesgo de transmisión rábica en la predación de quirópteros por carnívoros domésticos, Vet. Argentina (1987) 42:119-124.
  13. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A., DNA vaccines, Ann. Rev. Immunol. (1997) 15:617-648 [CrossRef].
  14. Eriksson A.M., Schon K.M., Lycke N.Y., The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues, J. Immunol. (2004) 173:3310-3319 [PubMed].
  15. Forg P., Von Hoegen P., Dalemans W., Schirrmacher V., Superiority of the ear pinnae over muscle tissue as site for DNA vaccination, Gene Ther. (1998) 5:789-797 [CrossRef] [PubMed].
  16. Frey A., Neutra M.R., Targeting of mucosal vaccines to Peyer's patch M cells, Behring Inst. Mitt. (1997) 98:376-389 [PubMed].
  17. Gallegos Gallegos R.M., Espinosa Larios E.L., Ramos Ramirez L., Kretschmer S.R., Aguilar Setien A., Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor, Arch. Med. Res. (1995) 26:59-63 [PubMed].
  18. Gómez-Carro S., Ortiz-Alcaraz M.L., Jiménez-Ríos E., De Los Santos-Briones S., Marín-Pech E., Estudio de caso de rabia humana transmitida por murciélago hematófago en Yucatán, México, Rev. Biomed. (2006) 17:118-122.
  19. Grassi M., Wandeler A., Peterhans E., Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus, J. Clin. Microbiol. (1989) 27:899-902 [PubMed].
  20. Hu R., Zhang S., Fooks A.R., Yuan H., Liu Y., Li H., Tu C., Xia X., Xiao Y., Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein, Microbes Infect. (2006) 8:1090-1097 [CrossRef] [PubMed].
  21. Li J., Faber M., Papaneri A., Faber M.L., McGettigan J.P., Schnell M.J., Dietzschold B., A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice, Virology (2006) 356:147-154 [CrossRef] [PubMed].
  22. Lodmell D.L., Parnell M.J., Weyhrich J., Ewalt L.O., Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinna elicits elevated and persistent levels of neutralizing antibody, Vaccine (2003) 21:3998-4002 [CrossRef] [PubMed].
  23. Lodmell D.L., Ewalt L.C., Parnell M.J., Rupprecht C.E., Hanlon C.A., One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus, Vaccine (2006) 24:412-416 [CrossRef] [PubMed].
  24. Loza Rubio E., Aguilar Setién A., Bahloul C., Brochier B., Pastoret P.P., Tordo N., Discrimination between epidemiological cycles of rabies in Mexico, Arch. Med. Res. (1999) 30:144-149 [CrossRef] [PubMed].
  25. Meslin F.X., Kaplan M.M., Koprowski H., Laboratory techniques in rabies, 4th edition, World Health Organization, Geneva, Switzerland, 1996.
  26. Meslin F., Global review of human and animal rabies, Rabies: guidelines for medical professionals, Veterinary Learning Systems, Trenton, NJ, USA, 1999.
  27. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., Spyr C., Steffen R., Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland, N. Engl. J. Med. (2004) 350:896-903 [CrossRef] [PubMed].
  28. Oh Y.K., Kim J.P., Hwang T.S., Ko J.J., Kim J.M., Yang J.S., Kim C.K., Nasal absorption and bio-distribution of plasmid DNA: an alternative route of DNA vaccine delivery, Vaccine (2001) 19:4519-4525 [CrossRef] [PubMed].
  29. Osorio J.E., Tomlinson C.C., Frank R.S., Haanes E.J., Rushlow K., Haynes J.R., Stinchcomb D.T., Immunization of dogs and cats with a DNA vaccine against rabies virus, Vaccine (1999) 17:1109-1116 [CrossRef] [PubMed].
  30. Paoletti E., Applications of pox virus vectors to vaccination: an update, Proc. Natl. Acad. Sci. USA (1996) 93:11349-11353 [CrossRef] [PubMed].
  31. Pastoret P.P., Brochier B., Epidemiology and control of fox rabies in Europe, Vaccine (1999) 17:1750-1754 [CrossRef] [PubMed].
  32. Perrin P., Techniques for the preparation of rabies conjugates, in: Meslin F.X., Kaplan M., Koprowski H. (Eds.), Laboratory techniques in rabies, 4th edition, World Health Organization, Geneva, Switzerland, 1996.
  33. Perrin P., Jacob Y., Aguilar-Setién A., Loza-Rubio E., Jallet C., Desmézières E., Aubert M., Cliquet F., Tordo N., Immunization of dogs with a DNA vaccine induces protection against rabies virus, Vaccine (1999) 18:479-486 [CrossRef] [PubMed].
  34. Rudmann D.G., Van Alstine W.G., Doddy F., Sandusky G.E., Barkdull T., Janovitz EB., Pulmonary and mediastinal metastases of a vaccination-site sarcoma in a cat, Vet. Pathol. (1996) 33:466-469 [PubMed].
  35. Rupprecht C.E., Hamir A.N., Jhonston D.H., Koprowski H., Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor), Rev. Infect. Dis. (1988) 10:S803-S809 [PubMed].
  36. Schneider L.G., Rabies virus vaccines, Dev. Biol. Stand. (1995) 84:49-54 [PubMed].
  37. Smith J.S., Yager P.A., Baer G.A., A rapid fluorescent focus inhibition test (RFFIT) for determining rabies neutralizing antibodies, in: Meslin F.X., Kaplan M.M., Koprowski H. (Eds.), Laboratory Techniques in Rabies, 4th edition, World Health Organization, Geneva, Switzerland, 1996.
  38. Tesoro-Cruz E., Hernández-González R., Alonso-Morales R., Aguilar-Setién A., Rabies DNA vaccination by the intranasal route in dogs, Dev Biol (Basel) (2006) 125:221-231 [PubMed].
  39. Wunner W.H., Dietzschold B., Curtis P.J., Wiktor T.J., Rabies subunit vaccines, J. Gen. Virol. (1983) 64:1649-1656 [PubMed].
  40. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C., Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus, Virology (1994) 199:132-140 [CrossRef] [PubMed].
  41. Xiang Z.Q., Yang Y., Wilson J.M., Ertl H.C., A replication defective human adenovirus recombinant serves as a highly efficacious vaccine carrier, Virology (1996) 219:220-227 [CrossRef] [PubMed].